Skip to content

ENGN

enGene Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · CA

$1.91
+0.00%
Ask drillr

Leverage

Debt / equity
0.14x
Net debt / equity
-0.03x
Debt / assets
0.12x
Debt / EBITDA
-0.25x
Net debt / EBITDA
0.06x

Liquidity & coverage

Current ratio
10.21x
Quick ratio
10.21x
Cash ratio
9.79x
Interest coverage
-1.53x
EBITDA / interest
-42.97x
Working capital
$250.7M

Cash & dividend

FCF / debt
-3.13x
Cash flow / debt
-3.11x
Dividend per share
Dividend yield
Dividend growth 1y
-77.2%

Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jul 1, 2026